Log In
Print
BCIQ
Print
Print this Print this
 

MCNA (EN3348) (formerly Urocidin)

  Manage Alerts
Collapse Summary General Information
Company Telesta Therapeutics Inc.
DescriptionMycobacterial cell wall-DNA complex (MCC)
Molecular Target Not applicable
Mechanism of ActionImmune modulation; Apoptosis stimulator
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationBladder cancer
Indication DetailsTreat bladder cancer; Treat non-muscle invasive bladder cancer; Treat superficial bladder cancer (SBC)
Regulatory Designation

Partner

Endo International plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$145.4M

$20.0M

$125.4M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today